000			02038 a2200517 4500
005			20250516201623.0
264		0	_c20141222
008			201412s 0 0 eng d
022			_a1556-679X
024	7		_a10.1128/CVI.00807-13 _2doi
040			_aNLM _beng _cNLM
100	1		_aPauksens, Karlis
245	0	0	_aRandomized controlled study of the safety and immunogenicity of pneumococcal vaccine formulations containing PhtD and detoxified pneumolysin with alum or adjuvant system AS02V in elderly adults. _h[electronic resource]
260			_bClinical and vaccine immunology : CVI _cMay 2014
300			_a651-60 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdjuvants, Immunologic _xadministration & dosage
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAlum Compounds _xadministration & dosage
650	0	4	_aAntibodies, Bacterial _xblood
650	0	4	_aAntigens, Bacterial _ximmunology
650	0	4	_aBacterial Proteins _ximmunology
650	0	4	_aDrug-Related Side Effects and Adverse Reactions _xepidemiology
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aOpsonin Proteins _xblood
650	0	4	_aPhagocytosis
650	0	4	_aPlacebos _xadministration & dosage
650	0	4	_aPneumococcal Vaccines _xadministration & dosage
650	0	4	_aSaponins _xadministration & dosage
650	0	4	_aSingle-Blind Method
650	0	4	_aStreptolysins _ximmunology
650	0	4	_aVaccines, Subunit _xadministration & dosage
700	1		_aNilsson, Anna C
700	1		_aCaubet, Magalie
700	1		_aPascal, Thierry G
700	1		_aVan Belle, Pascale
700	1		_aPoolman, Jan T
700	1		_aVandepapelière, Pierre G
700	1		_aVerlant, Vincent
700	1		_aVink, Peter E
773	0		_tClinical and vaccine immunology : CVI _gvol. 21 _gno. 5 _gp. 651-60
856	4	0	_uhttps://doi.org/10.1128/CVI.00807-13 _zAvailable from publisher's website
999			_c23613722 _d23613722